These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33989979)

  • 1. Calcium-calcineurin signaling pathway in Candida albicans: A potential drug target.
    Li W; Shrivastava M; Lu H; Jiang Y
    Microbiol Res; 2021 Aug; 249():126786. PubMed ID: 33989979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the fungal calcium-calcineurin signaling network in overcoming drug resistance.
    Li X; Sun S
    Future Med Chem; 2016 Aug; 8(12):1379-81. PubMed ID: 27463738
    [No Abstract]   [Full Text] [Related]  

  • 3. Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin.
    Singh SD; Robbins N; Zaas AK; Schell WA; Perfect JR; Cowen LE
    PLoS Pathog; 2009 Jul; 5(7):e1000532. PubMed ID: 19649312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Components of the calcium-calcineurin signaling pathway in fungal cells and their potential as antifungal targets.
    Liu S; Hou Y; Liu W; Lu C; Wang W; Sun S
    Eukaryot Cell; 2015 Apr; 14(4):324-34. PubMed ID: 25636321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae.
    Zhang J; Silao FG; Bigol UG; Bungay AA; Nicolas MG; Heitman J; Chen YL
    PLoS One; 2012; 7(8):e44192. PubMed ID: 22952924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRZ1, a target of the calcineurin pathway in Candida albicans.
    Karababa M; Valentino E; Pardini G; Coste AT; Bille J; Sanglard D
    Mol Microbiol; 2006 Mar; 59(5):1429-51. PubMed ID: 16468987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cation Transporters of
    Volkova M; Atamas A; Tsarenko A; Rogachev A; Guskov A
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33923411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the Candida albicans calcineurin signaling cascade controlling stress response and virulence.
    Reedy JL; Filler SG; Heitman J
    Fungal Genet Biol; 2010 Feb; 47(2):107-16. PubMed ID: 19755168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90.
    LaFayette SL; Collins C; Zaas AK; Schell WA; Betancourt-Quiroz M; Gunatilaka AA; Perfect JR; Cowen LE
    PLoS Pathog; 2010 Aug; 6(8):e1001069. PubMed ID: 20865172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin promotes infection of the cornea by Candida albicans and can be targeted to enhance fluconazole therapy.
    Onyewu C; Afshari NA; Heitman J
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3963-5. PubMed ID: 16923949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-activated-calcineurin reduces the In vitro and In vivo sensitivity of fluconazole to Candida albicans via Rta2p.
    Jia Y; Tang RJ; Wang L; Zhang X; Wang Y; Jia XM; Jiang YY
    PLoS One; 2012; 7(10):e48369. PubMed ID: 23118995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miconazole induces aneuploidy-mediated tolerance in
    Guo L; Zheng L; Dong Y; Wang C; Deng H; Wang Z; Xu Y
    Front Cell Infect Microbiol; 2024; 14():1392564. PubMed ID: 38983116
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Gong Y; Li T; Yu C; Sun S
    Front Cell Infect Microbiol; 2017; 7():520. PubMed ID: 29312897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinases as potential anticandidal drug targets.
    Singh S; Rehman S; Fatima Z; Hameed S
    Front Biosci (Landmark Ed); 2020 Mar; 25(8):1412-1432. PubMed ID: 32114439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone acetylation/deacetylation in
    Su S; Li X; Yang X; Li Y; Chen X; Sun S; Jia S
    Future Microbiol; 2020 Jul; 15():1075-1090. PubMed ID: 32854542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Targets for Antifungal Drug Discovery Based on Growth and Virulence in Candida albicans.
    Li X; Hou Y; Yue L; Liu S; Du J; Sun S
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5885-91. PubMed ID: 26195510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Elucidation of Riboflavin Production and Regulation in Candida albicans, toward a Novel Antifungal Drug Target.
    Demuyser L; Palmans I; Vandecruys P; Van Dijck P
    mSphere; 2020 Aug; 5(4):. PubMed ID: 32759338
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach.
    Juvvadi PR; Lee SC; Heitman J; Steinbach WJ
    Virulence; 2017 Feb; 8(2):186-197. PubMed ID: 27325145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of G234 amino acid residue in candida albicans drug-resistance-related protein Rta2p is associated with fluconazole resistance and dihydrosphingosine transport.
    Zhang SQ; Miao Q; Li LP; Zhang LL; Yan L; Jia Y; Cao YB; Jiang YY
    Virulence; 2015; 6(6):599-607. PubMed ID: 26220356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal polybrominated proxyphylline derivative induces Candida albicans calcineurin stress response in Galleria mellonella.
    Gizińska M; Staniszewska A; Kazek M; Koronkiewicz M; Kuryk Ł; Milner-Krawczyk M; Baran J; Borowiecki P; Staniszewska M
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127545. PubMed ID: 32931913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.